Updated

Origin Genomics, a biotech startup, is working to demonstrate that editing disease-causing genes in human embryos can be done safely, arguing the potential health benefits for future children outweigh the risks. The effort touches on one of biotechnology's most ethically contentious frontiers, as regulators and bioethicists continue to debate the acceptability of heritable human gene editing.